Skip to main content
SleepCited

Cannabidiol as a personalized treatment for anxiety: clinical cases in Mexico.

Flor Cristina Ortiz Rios, Itzel Guadalupe Dávila Ruiz, Elisa Sacal Dumani
Case Report Drugs in context 2022 6 citations
PubMed DOI
<\/script>\n
`; }, get iframeSnippet() { const domain = 'sleepcited.com'; const params = 'pmid\u003D36188636'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Study Design

Study Type
Case Reports
Sample Size
3
Population
Patients with anxiety disorders in Mexico
Intervention
Cannabidiol as a personalized treatment for anxiety: clinical cases in Mexico. None
Comparator
None
Primary Outcome
Anxiety symptom improvement
Effect Direction
Positive
Risk of Bias
High

Abstract

Anxiety-related disorders are one of the most common mental health issues worldwide. Mexico has reported an increase in the prevalence of these ailments secondary to the confinement derived from the COVID-19 pandemic. Given the limitations of commonly used treatments for these disorders, a need arises to develop new pharmacological treatments for these patients. This paper has the primary objective of evaluating the efficacy and safety of cannabidiol isolate in drug compounding used as a personalized treatment in patients with anxiety disorders through the presentation of four clinical cases.

TL;DR

Evaluating the efficacy and safety of cannabidiol isolate in drug compounding used as a personalized treatment in patients with anxiety disorders through the presentation of four clinical cases is evaluated.

Used In Evidence Reviews

Similar Papers